Navigation Links
Red Cross Blood Supplies Reach Dangerous Levels

Blood supplies in southeastern Michigan have been depleted due to emergency needs and low donor turnout. The American Red Cross is issuing a call to action to everyone who can, to donate blood.

As of this morning, the Southeastern Michigan Blood Service Region of the American Red Cross had no units of Type O-negative -- the universal blood type -- on its shelves. Type B-negative was below a one-day supply.

Shortages of Type O-negative can be serious since hospitals may use it in most emergency trauma cases when there is not enough time to determine a patient's blood type. Shortages of Type B-negative compound the situation since people with Type B-negative can only receive blood from Type O-negative or Type B-negative donors. The shortage of these two blood types, according to Red Cross officials, has been the norm for the past year or more, and individuals with these blood types make up just nine percent of the general population.

'Donations of Type O-negative and Type B-negative blood are the most crucial, but we are calling on all eligible donors -- regardless of blood type -- to help ensure that blood is available when needed. Other blood types are at dangerously low levels as well,' says Diane Ward, CEO of the American Red Cross Southeastern Michigan Blood Services Region.

Traditionally, the Red Cross sees a drop in donations during the summer months due to vacations and other activities. However, the need for blood grows because of increased highway accidents and other hospital emergencies.

'The Red Cross is encouraging new and previous blood donors to join the battle against summer blood shortages,' Ward adds. 'Make a date to give blood once, or even twice, between June and September. Each time you give, you can help save up to three lives.'

Blood donors must be at least 17 years old, weigh at least 110 pounds and be in good general health.


'"/>




Page: 1

Related medicine news :

1. FDA attacks American Red Cross for blood violations
2. Encephalitis Death Toll In U.P. Crosses 200 Mark.
3. Encephalitis Deaths Cross 220 in Uttar Pradesh
4. First Crossover Kidney Transplantation In Germany
5. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
6. Red Cross Says Fund Boost and Awareness Are the Main Ingredients to Fight AIDS
7. Salutations For The Selfless Heroes On World Red Cross Day
8. Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity
9. Viruses Can Cross Species Barrier
10. American Red Cross Fined by FDA over Blood Collection Practices
11. American Red Cross Fined $4.2m for Improper Blood Screening
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... RYE, New York (PRWEB) , ... February 23, 2017 , ... ... to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, ... the 30 clinical sites already enrolling children across the United States. , “There ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane ... overwork even the sharpest brain. , Power On, a mental performance enhancer from ... clocking the brain. Each capsule contains Cognizin® Citicoline, a branded form of the ...
(Date:2/22/2017)... ... ... The National Academy of Certified Care Managers (NACCM) has ... period. NACCM, a nonprofit organization, has provided the premier certification for Care Managers ... to ensure that newly certified professionals are prepared to work effectively on behalf ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology: